Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE49.9500
- TODAY'S CHANGE (%)1.2900 (2.6510%)
- Bid / Lots45.5800/ 1
- Ask / Lots53.6100/ 1
- Open / Previous Close50.0000 / 48.6600
- Day Range
- 52 Week Range
- Volume341,121
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 2174 | 50 |
| 09:36 ET | 1705 | 50.145 |
| 09:38 ET | 497 | 50.25 |
| 09:39 ET | 800 | 50.315 |
| 09:41 ET | 603 | 50.17 |
| 09:43 ET | 300 | 50.055 |
| 09:48 ET | 300 | 50.11 |
| 09:50 ET | 2000 | 49.63 |
| 09:52 ET | 4932 | 50.06 |
| 09:54 ET | 4007 | 50.205 |
| 09:56 ET | 695 | 50.44 |
| 09:57 ET | 100 | 49.865 |
| 09:59 ET | 200 | 50.135 |
| 10:01 ET | 4110 | 50.09 |
| 10:03 ET | 2181 | 50 |
| 10:06 ET | 800 | 50.27 |
| 10:08 ET | 200 | 49.67 |
| 10:10 ET | 3585 | 49.35 |
| 10:14 ET | 600 | 49.46 |
| 10:17 ET | 2129 | 49.4 |
| 10:19 ET | 100 | 49.42 |
| 10:21 ET | 100 | 49.41 |
| 10:24 ET | 500 | 49.53 |
| 10:26 ET | 1200 | 49.54 |
| 10:28 ET | 1117 | 49.555 |
| 10:30 ET | 558 | 49.36 |
| 10:32 ET | 412 | 49.425 |
| 10:33 ET | 3301 | 49.42 |
| 10:35 ET | 388 | 49.51 |
| 10:37 ET | 600 | 49.515 |
| 10:39 ET | 1000 | 49.575 |
| 10:42 ET | 900 | 49.56 |
| 10:44 ET | 300 | 49.585 |
| 10:46 ET | 200 | 49.585 |
| 10:48 ET | 105 | 49.585 |
| 10:50 ET | 500 | 49.5 |
| 10:51 ET | 500 | 49.41 |
| 10:53 ET | 100 | 49.295 |
| 10:55 ET | 313 | 49.15 |
| 10:57 ET | 2200 | 49.585 |
| 11:00 ET | 600 | 49.565 |
| 11:02 ET | 100 | 49.54 |
| 11:04 ET | 500 | 49.575 |
| 11:08 ET | 298 | 49.57 |
| 11:11 ET | 300 | 49.54 |
| 11:13 ET | 733 | 49.445 |
| 11:18 ET | 200 | 49.365 |
| 11:20 ET | 300 | 49.37 |
| 11:22 ET | 400 | 49.37 |
| 11:24 ET | 800 | 49.32 |
| 11:26 ET | 1200 | 49.43 |
| 11:27 ET | 300 | 49.53 |
| 11:29 ET | 600 | 49.34 |
| 11:31 ET | 200 | 49.425 |
| 11:33 ET | 800 | 49.43 |
| 11:38 ET | 1216 | 49.475 |
| 11:40 ET | 1700 | 49.575 |
| 11:42 ET | 7496 | 49.275 |
| 11:45 ET | 200 | 49.37 |
| 11:47 ET | 200 | 49.395 |
| 11:49 ET | 400 | 49.33 |
| 11:54 ET | 2448 | 49.32 |
| 11:56 ET | 300 | 49.35 |
| 11:58 ET | 200 | 49.17 |
| 12:00 ET | 100 | 49.24 |
| 12:02 ET | 108 | 49.245 |
| 12:03 ET | 217 | 49.15 |
| 12:05 ET | 300 | 49.12 |
| 12:07 ET | 200 | 49.07 |
| 12:09 ET | 200 | 49.205 |
| 12:12 ET | 100 | 49.11 |
| 12:14 ET | 954 | 49.195 |
| 12:16 ET | 1060 | 49.075 |
| 12:18 ET | 200 | 49 |
| 12:20 ET | 200 | 48.98 |
| 12:21 ET | 714 | 48.96 |
| 12:23 ET | 719 | 48.95 |
| 12:25 ET | 500 | 48.915 |
| 12:27 ET | 1600 | 49.02 |
| 12:30 ET | 1480 | 49.24 |
| 12:38 ET | 200 | 49.26 |
| 12:39 ET | 100 | 49.13 |
| 12:41 ET | 500 | 49.13 |
| 12:43 ET | 200 | 49.255 |
| 12:48 ET | 990 | 49.39 |
| 12:50 ET | 300 | 49.39 |
| 12:52 ET | 500 | 49.4 |
| 12:54 ET | 198 | 49.39 |
| 12:56 ET | 200 | 49.41 |
| 12:57 ET | 100 | 49.43 |
| 12:59 ET | 300 | 49.42 |
| 01:01 ET | 400 | 49.5 |
| 01:03 ET | 100 | 49.42 |
| 01:06 ET | 500 | 49.485 |
| 01:08 ET | 500 | 49.52 |
| 01:10 ET | 100 | 49.465 |
| 01:12 ET | 200 | 49.53 |
| 01:14 ET | 400 | 49.53 |
| 01:15 ET | 100 | 49.48 |
| 01:17 ET | 100 | 49.5 |
| 01:19 ET | 400 | 49.5 |
| 01:21 ET | 100 | 49.4 |
| 01:24 ET | 400 | 49.4 |
| 01:26 ET | 3483 | 49.45 |
| 01:30 ET | 200 | 49.54 |
| 01:32 ET | 734 | 49.48 |
| 01:35 ET | 900 | 49.17 |
| 01:37 ET | 300 | 49.43 |
| 01:42 ET | 100 | 49.245 |
| 01:44 ET | 100 | 49.43 |
| 01:46 ET | 1000 | 49.61 |
| 01:48 ET | 112 | 49.35 |
| 01:50 ET | 200 | 49.445 |
| 01:51 ET | 1720 | 49.43 |
| 01:53 ET | 305 | 49.455 |
| 01:57 ET | 100 | 49.455 |
| 02:00 ET | 600 | 49.59 |
| 02:02 ET | 497 | 49.5 |
| 02:04 ET | 100 | 49.5 |
| 02:06 ET | 300 | 49.55 |
| 02:08 ET | 1910 | 49.69 |
| 02:09 ET | 1744 | 49.74 |
| 02:11 ET | 100 | 49.75 |
| 02:13 ET | 200 | 49.745 |
| 02:18 ET | 300 | 49.78 |
| 02:20 ET | 1416 | 49.94 |
| 02:22 ET | 962 | 49.9 |
| 02:27 ET | 518 | 50.055 |
| 02:29 ET | 200 | 50.05 |
| 02:33 ET | 200 | 49.975 |
| 02:36 ET | 1523 | 49.8725 |
| 02:40 ET | 649 | 49.94 |
| 02:42 ET | 700 | 49.92 |
| 02:44 ET | 200 | 49.925 |
| 02:45 ET | 300 | 49.98 |
| 02:47 ET | 100 | 50.05 |
| 02:51 ET | 1121 | 49.97 |
| 02:54 ET | 300 | 50.02 |
| 02:56 ET | 400 | 50.005 |
| 02:58 ET | 100 | 49.995 |
| 03:00 ET | 200 | 50.05 |
| 03:02 ET | 100 | 49.995 |
| 03:03 ET | 502 | 49.87 |
| 03:05 ET | 900 | 49.85 |
| 03:07 ET | 3086 | 50 |
| 03:09 ET | 1292 | 50 |
| 03:12 ET | 100 | 50 |
| 03:14 ET | 4147 | 50.03 |
| 03:16 ET | 400 | 49.95 |
| 03:18 ET | 419 | 49.99 |
| 03:20 ET | 229 | 49.985 |
| 03:21 ET | 300 | 49.98 |
| 03:23 ET | 300 | 49.975 |
| 03:25 ET | 676 | 49.95 |
| 03:27 ET | 6752 | 49.86 |
| 03:30 ET | 131 | 49.86 |
| 03:32 ET | 606 | 49.86 |
| 03:34 ET | 500 | 49.7 |
| 03:36 ET | 200 | 49.705 |
| 03:38 ET | 900 | 49.87 |
| 03:39 ET | 655 | 49.865 |
| 03:41 ET | 418 | 49.89 |
| 03:43 ET | 400 | 49.82 |
| 03:45 ET | 6720 | 49.81 |
| 03:48 ET | 1555 | 49.82 |
| 03:50 ET | 6065 | 49.855 |
| 03:52 ET | 13577 | 49.87 |
| 03:54 ET | 6136 | 49.7 |
| 03:56 ET | 3245 | 49.83 |
| 03:57 ET | 6729 | 49.84 |
| 03:59 ET | 10831 | 49.95 |
Jul 18, 2024
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors, from 8:00AM ET on Thursday Jul 18, 2024 by Dow Jones
8:00AM ET on Thursday Jul 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 2.8B | -24.4x | --- |
Morphic Holding Inc | 2.8B | -16.2x | --- |
MoonLake Immunotherapeutics | 2.9B | -59.7x | --- |
Celldex Therapeutics Inc | 2.9B | -15.7x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.4x | --- |
Iovance Biotherapeutics Inc | 2.6B | -5.1x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark Mckenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Lisa Bollinger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.04 |
Book Value | $7.86 |
P/E Ratio | -24.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
